Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Lymphoid 2Thoracic 1Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Breast 1

Conditions

Obesity 23Polycystic Ovary Syndrome 13Overweight 6Sexual Dysfunction, Physiological 5Neoplasms 5Mucositis 5Constipation 5Opioid-Induced Constipation 3Multiple Endocrine Neoplasia Type 1 3Inflammation 3Head and Neck Neoplasms 3Pain 2Nausea 2Lung Neoplasms 2Infertility 2Diabetes, Gestational 2Cancer-related Fatigue 2Cancer Pain 2Breast Neoplasms 2Xerostomia 1Weight Loss 1Vomiting 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Ulcer 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation-induced Oral Mucositis 1Prostatic Neoplasms 1Pregnancy Complications 1

Interventions

naldemedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Nausea × Other × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Mt. Sinai Medical Center, Miami

Phase 4 Completed
452 enrolled
Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡